SXTC
China SXT Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SXTC fundamentals
China SXT Pharmaceuticals (SXTC) released its earnings on Feb 24, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Feb 24, 2023
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What is China SXT Pharmaceuticals's latest dividend and current dividend yield?What guidance did China SXT Pharmaceuticals's management provide for the next earnings period?Did China SXT Pharmaceuticals beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for China SXT Pharmaceuticals year over year?What factors drove the changes in China SXT Pharmaceuticals's revenue and profit?What does China SXT Pharmaceuticals do and what are its main business segments?What were the key takeaways from China SXT Pharmaceuticals's earnings call?What were the key takeaways from China SXT Pharmaceuticals’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
